Effects of the flavonoid biochanin A on gene expression in primary human hepatocytes and human intestinal cells

Molecular Nutrition and Food Research

Volumn 51, Issue 3, 2007, Pages 317-323

  Moon, Young Jin ^a   Zhang, Shuzhong ^b   Brazeau, Daniel A ^a   Morris, Marilyn E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biochanin A; Drug interaction; Hepatocytes; LS 180; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; ARYL SULFOTRANSFERASE; BIOCHANIN A; COUMARIN 7 HYDROXYLASE; COUMARIN 7-HYDROXYLASE; CYP2C9 PROTEIN, HUMAN; CYP2F1 PROTEIN, HUMAN; CYTOCHROME P450; GENISTEIN; GLYCOPROTEIN P; MIXED FUNCTION OXIDASE; N DEMETHYLASE; S MEPHENYTOIN N DEMETHYLASE; S-MEPHENYTOIN N-DEMETHYLASE; SULT1A2 PROTEIN, HUMAN; THROMBOXANE SYNTHASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ADENOCARCINOMA; ARTICLE; COLON TUMOR; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; INTESTINE CELL; LIVER CELL; METABOLISM; TUMOR CELL LINE; UPREGULATION;

ADENOCARCINOMA; ANTICARCINOGENIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; ARYLSULFOTRANSFERASE; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; ENTEROCYTES; GENE EXPRESSION; GENISTEIN; HEPATOCYTES; HUMANS; MIXED FUNCTION OXYGENASES; OXIDOREDUCTASES, N-DEMETHYLATING; P-GLYCOPROTEIN; THROMBOXANE-A SYNTHASE; UP-REGULATION;

EID: 34250175510     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200600156     Document Type: Article

References (39)

1. Rice, L., Samedi, V. G., Medrano, T. A., Sweeney, C. A., et al., Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts, Prostate 2002, 52, 201-212.
2. Merz-Demlow, B. E., Duncan, A. M., Wangen, K. E., Xu, X., et al., Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women, Am. J. Clin. Nutr. 2000, 71, 1462-1469.
3. Lissin, L. W., Cooke, J. P., Phytoestrogens and cardiovascular health, J. Am. Coll. Cardiol. 2000, 35, 1403-1410.
4. Chan, H. Y., Wang, H., Leung, L. K., The red clover (Trifolium pratense) isoflavone biochanin A modulates the bio-transformation pathways of 7,12-dimethylbenz[a]anthracene, Br. J. Nutr. 2003, 90, 87-92.
5. Sun, X. Y., Plouzek, C. A., Henry, J. P., Wang, T. T., et al., Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells, Cancer Res. 1998, 58, 2379-2384.
6. Kao, Y. C., Zhou, C., Sherman, M., Laughton, C. A., et al., Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study, Environ. Health Perspect. 1998, 106, 85-92.
7. Gomez-Lechon, M. J., Donato, M. T., Castell, J. V, Jover, R., Human hepatocytes in primary culture: the choice to investigate drug metabolism in man, Curr. Drug Metab. 2004, 5, 443-462.
8. Li, A. P., Maurel, P., Gomez-Lechon, M. J., Cheng, L. C., et al., Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction, Chem. Biol. Interact. 1997, 107, 5-16.
9. Collett, A., Tanianis-Hughes, J., Warhurst, G., Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?, Biochem. Pharmacol. 2004, 68, 783-790.
10. Thummel, K. E., Brimer, C., Yasuda, K., Thottassery, J., et al., Transcriptional control of intestinal cytochrome P-4503 A by 1 alpha,25-dihydroxy vitamin D3, Mol. Pharmacol. 2001, 60, 1399-1406.
11. Wang, S. W, Chen, J., Jia, X., Tam, V. H., et al., Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties, Drug Metab. Dispos. 2006, 34, 1837-1848.
12. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., et al., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol. 2002, 3, RESEARCH0034.
13. Zhang, S., Morris, M. E., Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport, J. Pharmacol. Exp. Ther. 2003, 304, 1258-1267.
14. Tusher, V. G., Tibshirani, R., Chu, G., Significance analysis of microarrays applied to the ionizing radiation response, Proc. Natl. Acad. Sci. USA 2001, 98, 5116-5121.
15. Nishimura, M., Naito, S., Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes, Drug Metab. Pharmacokinet. 2006, 21, 357-374.
16. Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., et al., Human sulfotransferases and their role in chemical metabolism, Toxicol. Sci. 2006, 90, 5-22.
17. Furukawa, M., Nishimura, M., Ogino, D., Chiba, R., et al., Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver, Cancer Sci. 2004, 95, 520-529.
18. Nishimura, M., Yaguti, H., Yoshitsugu, H., Naito, S., et al., Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR, Yakugaku Zasshi 2003, 123, 369-375.
19. Her, C., Kaur, G. P., Athwal, R. S., Weinshilboum, R. M., Human sulfotransferase SULT1C1: cDNA cloning, tissue-specific expression, and chromosomal localization, Genomics 1997, 41, 467-470.
20. Nishimura, M., Yoshitsugu, H., Naito, S., Hiraoka, I., Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR, Yakugaku Zasshi 2002, 122, 339-361.
21. Burk, O., Arnold, K. A., Geick, A., Tegude, H., et al., A role for constitutive androstane receptor in the regulation of human intestinal MDRI expression, Biol. Chem. 2005, 386, 503-513.
22. Waxman, D. J., P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR, Arch. Biochem. Biophys. 1999, 369, 11-23.
23. Moore, J. T., Kliewer, S. A., Use of the nuclear receptor PXR to predict drug interactions, Toxicology 2000, 153, 1-10.
24. Thevenod, F., Friedmann, J. M., Katsen, A. D., Hauser, I. A., Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen speciesinduced apoptosis, J. Biol. Chem. 2000, 275, 1887-1896.
25. Misra, S., Ghatak, S., Toole, B. P., Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2, J. Biol. Chem. 2005, 280, 20310-20315.
26. Sarkar, F. H., Li, Y., Mechanisms of cancer chemoprevention by soy isoflavone genistein, Cancer Metastasis Rev. 2002, 21, 265-280.
27. Wang, H., Faucette, S., Sueyoshi, T., Moore, R., et al., A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression, J. Biol. Chem. 2003, 278, 14146-14152.
28. Xie, W., Evans, R. M., Orphan nuclear receptors: the exotics of xenobiotics, J. Biol. Chem. 2001, 276, 37739-37742.
29. Miners, J. O., Birkett, D. J., Cytochrome P4502C9: an enzyme of major importance in human drug metabolism, Br. J. Clin. Pharmacol. 1998, 45, 525-538.
30. Drocourt, L., Ourlin, J. C., Pascussi, J. M., Maurel, P., et al., Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes, J. Biol. Chem. 2002, 277, 25125-25132.
31. Kulling, S. E., Lehmann, L., Metzler, M., Oxidative metabolism and genotoxic potential of major isoflavone phytoestrogens, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 777, 211-218.
32. Cross, H. S., Kallay, E., Lechner, D., Gerdenitsch, W., et al., Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas, J. Nutr. 2004, 134, 1207S-1212S.
33. Wietzke, J. A., Welsh, J., Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells, J. Steroid Biochem. Mol. Biol. 2003, 84, 149-157.
34. Chase, M. B., Baek, S. J., Purtell, D. C., Schwartz, S., et al., Mapping of the human thromboxane synthase gene (TBXAS1) to chromosome 7q34-q35 by two-color fluorescence in situ hybridization, Genomics 1993, 16, 771-773.
35. Falany, C. N., Enzymology of human cytosolic sulfotransferases, FASEB J. 1997, 11, 206-216.
36. Meinl, W., Meerman, J. H., Glatt, H., Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium, Pharmacogenetics 2002, 12, 677-689.
37. Harris, R. M., Wood, D. M., Bottomley, L., Blagg, S., et al., Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment, J. Clin. Endocrinol. Metab. 2004, 89, 1779-1787.
38. Zhang, S., Morris, M. E., Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells, Pharm. Res. 2003, 20, 1184-1191.
39. Izumi, T., Piskula, M. K., Osawa, S., Obata, A., et al., Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans, J. Nutr. 2000, 130, 1695-1699.